Association between emphysema-like lung on cardiac computed tomography and mortality in persons without airflow obstruction: a cohort study
- PMID: 25506855
- PMCID: PMC4347817
- DOI: 10.7326/M13-2570
Association between emphysema-like lung on cardiac computed tomography and mortality in persons without airflow obstruction: a cohort study
Abstract
Background: Low lung function is known to predict mortality in the general population, but the prognostic significance of emphysema on computed tomography (CT) in persons without chronic obstructive pulmonary disease (COPD) is uncertain.
Objective: To determine whether greater emphysema-like lung on CT is associated with all-cause mortality among persons in the general population without airflow obstruction or COPD.
Design: Prospective cohort study.
Setting: Population-based, multiethnic sample from 6 U.S. communities.
Participants: 2965 participants aged 45 to 84 years without airflow obstruction on spirometry.
Measurements: Emphysema-like lung was defined as the number of lung voxels with attenuation less than -950 Hounsfield units on cardiac CT and was adjusted for the number of total imaged lung voxels.
Results: Among 2965 participants, 50.9% of whom had never smoked, there were 186 deaths over a median of 6.2 years. Greater emphysema-like lung was independently associated with increased mortality (adjusted hazard ratio per one-half interquartile range, 1.14 [95% CI, 1.04 to 1.24]; P=0.004) after adjustment for potential confounders, including cardiovascular risk factors and FEV1. Generalized additive models supported a linear association between emphysema-like lung and mortality without evidence for a threshold. The association was of greatest magnitude among smokers, although multiplicative interaction terms did not support effect modification by smoking status.
Limitations: Cardiac CT scans did not include lung apices. The number of deaths was limited among subgroup analyses.
Conclusion: Emphysema-like lung on CT was associated with all-cause mortality among persons without airflow obstruction or COPD in a general population sample, particularly among smokers. Recognition of the independent prognostic significance of emphysema on CT among patients without COPD on spirometry is warranted.
Primary funding source: National Heart, Lung, and Blood Institute.
Conflict of interest statement
Figures
Similar articles
-
Per cent emphysema is associated with respiratory and lung cancer mortality in the general population: a cohort study.Thorax. 2016 Jul;71(7):624-32. doi: 10.1136/thoraxjnl-2015-207822. Epub 2016 Apr 5. Thorax. 2016. PMID: 27048196 Free PMC article.
-
Percent emphysema, airflow obstruction, and impaired left ventricular filling.N Engl J Med. 2010 Jan 21;362(3):217-27. doi: 10.1056/NEJMoa0808836. N Engl J Med. 2010. PMID: 20089972 Free PMC article.
-
Quantitative Emphysema on Low-Dose CT Imaging of the Chest and Risk of Lung Cancer and Airflow Obstruction: An Analysis of the National Lung Screening Trial.Chest. 2021 May;159(5):1812-1820. doi: 10.1016/j.chest.2020.12.004. Epub 2020 Dec 14. Chest. 2021. PMID: 33326807 Free PMC article.
-
Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: Relationship to physiological measurements, clinical index and visual assessment of airway disease.Eur J Radiol. 2016 Nov;85(11):2144-2151. doi: 10.1016/j.ejrad.2016.09.010. Epub 2016 Sep 13. Eur J Radiol. 2016. PMID: 27776670 Free PMC article. Review.
-
Improving Detection of Early Chronic Obstructive Pulmonary Disease.Ann Am Thorac Soc. 2018 Dec;15(Suppl 4):S243-S248. doi: 10.1513/AnnalsATS.201808-529MG. Ann Am Thorac Soc. 2018. PMID: 30759006 Free PMC article. Review.
Cited by
-
Update of prognosis and characteristics of chronic obstructive pulmonary disease in a real-world setting: a 5-year follow-up analysis of a multi-institutional registry.BMC Pulm Med. 2024 Nov 6;24(1):556. doi: 10.1186/s12890-024-03347-5. BMC Pulm Med. 2024. PMID: 39506773 Free PMC article.
-
UNSUPERVISED DOMAIN ADAPTION WITH ADVERSARIAL LEARNING (UDAA) FOR EMPHYSEMA SUBTYPING ON CARDIAC CT SCANS: THE MESA STUDY.Proc IEEE Int Symp Biomed Imaging. 2019 Apr;2019:289-293. doi: 10.1109/isbi.2019.8759525. Epub 2019 Jul 11. Proc IEEE Int Symp Biomed Imaging. 2019. PMID: 39398279 Free PMC article.
-
Indices of Childhood Socioeconomic Status and Dysanapsis among Older Adults: The Multi-Ethnic Study of Atherosclerosis Lung Study.Ann Am Thorac Soc. 2024 Sep;21(9):1338-1342. doi: 10.1513/AnnalsATS.202401-006RL. Ann Am Thorac Soc. 2024. PMID: 38747708 No abstract available.
-
Pulmonary emphysema subtypes defined by unsupervised machine learning on CT scans.Thorax. 2023 Nov;78(11):1067-1079. doi: 10.1136/thorax-2022-219158. Epub 2023 Jun 2. Thorax. 2023. PMID: 37268414 Free PMC article.
-
Clinical features and 1-year outcomes of chronic bronchitis in participants with normal spirometry: results from the ECOPD study in China.BMJ Open Respir Res. 2023 Apr;10(1):e001449. doi: 10.1136/bmjresp-2022-001449. BMJ Open Respir Res. 2023. PMID: 37028909 Free PMC article.
References
-
- Minino AM, Murphy SL, Xu J, Kochanek KD. Deaths: final data for 2008. Natl Vital Stat Rep. 2011;59(10):1–126. - PubMed
-
- Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65. - PubMed
-
- Karner C, Chong J, Poole P. Tiotropium versus placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012;7:CD009285. - PubMed
Publication types
MeSH terms
Grants and funding
- N01-HC-95162/HC/NHLBI NIH HHS/United States
- R01 HL112986/HL/NHLBI NIH HHS/United States
- UL1 RR024156/RR/NCRR NIH HHS/United States
- N01-HC-95165/HC/NHLBI NIH HHS/United States
- R01 HL093081/HL/NHLBI NIH HHS/United States
- R01-HL077612/HL/NHLBI NIH HHS/United States
- N01HC95159/HL/NHLBI NIH HHS/United States
- N01-HC-95160/HC/NHLBI NIH HHS/United States
- N01-HC-95161/HC/NHLBI NIH HHS/United States
- K24 HL103844/HL/NHLBI NIH HHS/United States
- R01-93081/PHS HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- UL1-RR-025005/RR/NCRR NIH HHS/United States
- N01-HC-95163/HC/NHLBI NIH HHS/United States
- N01-HC-95168/HC/NHLBI NIH HHS/United States
- N01HC95169/HL/NHLBI NIH HHS/United States
- UL1-RR-024156/RR/NCRR NIH HHS/United States
- R01 HL077612/HL/NHLBI NIH HHS/United States
- N01-HC-95159/HC/NHLBI NIH HHS/United States
- RC1 HL100543/HL/NHLBI NIH HHS/United States
- N01-HC-95169/HC/NHLBI NIH HHS/United States
- N01-HC-95164/HC/NHLBI NIH HHS/United States
- R01 HL103676/HL/NHLBI NIH HHS/United States
- N01-HC-95166/HC/NHLBI NIH HHS/United States
- N01-HC-95167/HC/NHLBI NIH HHS/United States
- P30 ES009089/ES/NIEHS NIH HHS/United States
- RC1-100543/RC/CCR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical